NCT03357263已完成1 期
Randomized, Single-Blind, Active Comparator-controlled Study to Evaluate the Safety and Immunological Efficacy of GC3114 in Healthy Adults.
适应症
干预措施
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Adverse Event
研究概览
简要总结
Healthy adults will be once administered GC3114A(High-dose Quadrivalent influenza vaccine) or GCFLU Quadrivalent Pre-filled syringe inj..
详细描述
Healthy adults will be once administered GC3114A(High-dose Quadrivalent influenza vaccine) or GCFLU Quadrivalent Pre-filled syringe inj.. Safety and immunological efficacy will be evaluated.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 19 Years 至 64 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy adults aged 19-64 years old
- •Informed consent form has been signed and dated
- •Able to comply with the requirements of the study
排除标准
- •Known systemic hypersensitive to eggs, chicken proteins, or any of the vaccine components
- •Personal history of Guillain-Barre syndrome(GBS)
- •Subjects with severe chronic disease who are considered by investigator to be ineligible for the study
- •Subjects who received a vaccination within 28 days before enrollment or who are scheduled for another vaccination during the study
- •Immunocompromised subjects with immunodeficiency disease or subjects receiving immunosuppressive or immunomodulating therapy
- •Pregnant or lactating women
研究组 & 干预措施
GC3114
Experimental
Pre-filled syringe inj., 0.5ml, Once, IM
干预措施: GC3114 (Biological)
GCFLU Quadrivalent
Active Comparator
Pre-filled syringe inj., 0.5ml, Once, IM
干预措施: GCFLU Quadrivalent (Biological)
结局指标
主要结局
Adverse Event
时间窗: for 7 days from Day0/during study period
Solicited/Unsolicited Adverse Event
次要结局
- Percentage of participants achieving pre-defined Seroconversion Before and following vaccination(Day 0 and Day 21)
- Percentage of participants achieving pre-defined Seroprotection Before and following vaccination(Day 0 and Day 21)
- Geometric Mean Titer and Geometric Mean Titer Ratios of Antibodies to the Investigational Product Before and Following vaccination(Day 0 and Day 21)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy SubjectsInfluenza, HumanNCT03657719Green Cross Corporation105
已完成
1 期
A Dose Ranging Study Comparing Different Combinations of Adjuvanted and Non-adjuvanted Influenza Vaccines in Healthy Children 6 to <36 Months of AgeInfluenzaNCT00848887Novartis410
已完成
3 期
Non-Inferiority Study Comparing the Subunit Vaccines Influvac and Agrippal in ChinaHealthyNCT00325260Solvay Pharmaceuticals900
已完成
1 期
Comparison of Flu Vaccine Doses in ChildrenInfluenzaNCT01164553National Institute of Allergy and Infectious Diseases (NIAID)243
已完成
4 期
Randomized Trial of High Dose Influenza Vaccine in Long Term Care SettingInfluenzaNCT01654224University of Pittsburgh205